Less Mechanics, More Thinking - David Fischel, CEO of Stereotaxis

“The whole point of robotic medical devices is to reduce the role of the surgeon as a "mechanic' and enhance their role as a strategist, thinker and designer of the therapy which is best for each patient,” says David Fischel who first became aware of the medtech company Stereotaxis as an investor. Fast forward a few years, and he is now the CEO, and very passionate about the possibilities of robotic devices and digitized operating rooms. For instance, a surgeon with vast experience in a certain procedure could be in one location guiding multiple other surgeons in underserved areas with less experience, thereby extending access to the highest quality of care. “Once you digitize OR information and put the physician behind a computer, you allow for a whole range of additional capabilities that can enhance surgery and improve care,” he adds. In this fascinating look at the future of medicine, Fischel and host Shiv Gaglani explore his company’s technology -- which uses magnetic fields to permit finer control of the tips of surgical catheters -- and the uses it could have beyond its current application in treating cardiac arrythmias. Fishel also explains how a small company gets the word out while being dwarfed by giant global medtech companies, and why it makes sense for medical students and early career professionals to think like investors.

Raise the Line · David Fischel, Shiv Gaglani